Ponesimod 20 mg

DRUG2 trials

Sponsors

Actelion

Conditions

HealthyMultiple Sclerosis

Phase 1

Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects

CompletedNCT02136888

ActelionHealthy

Start: 2011-08-31End: 2012-02-29Updated: 2014-05-13

Phase 2

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis

CompletedNCT01093326

ActelionMultiple Sclerosis

Start: 2010-05-12End: 2023-09-06Updated: 2025-03-30

Related Papers

Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial

Journal of Neurology Neurosurgery & Psychiatry2014-03-21147 citations